Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
University of Washington
University of Washington
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
University of California, Irvine
Massachusetts General Hospital
Dartmouth-Hitchcock Medical Center
Fred Hutchinson Cancer Center
Azienda Ospedaliero-Universitaria di Parma
Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas
University of Southern California
Washington University School of Medicine
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Icahn School of Medicine at Mount Sinai
University of Rochester
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Chicago
Stanford University
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
City of Hope Medical Center
Thomas Jefferson University
Thomas Jefferson University
Mayo Clinic
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
City of Hope Medical Center
M.D. Anderson Cancer Center
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
University of Virginia
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
M.D. Anderson Cancer Center
University of Alabama at Birmingham
Icahn School of Medicine at Mount Sinai
Fred Hutchinson Cancer Center
City of Hope Medical Center
Icahn School of Medicine at Mount Sinai
Ohio State University Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center
Ottawa Hospital Research Institute